Oncology Phase I Clinical Trials: Issues and Challenge : Phase II/III Trial Design
September 8, 2021
![]() | Claire Dees, MD, MSC, ScM Professor, Oncology |
![]() | Matthew I. Milowsky, MD The George Gabriel and Frances Gable Villere Distinguished Professor of Bladder and Genitourinary Cancer Research DisclaimerThe views expressed herein are those of the presenter(s), they do not necessarily reflect the views of the contracted organization, department, School of Medicine, nor the University of North Carolina at Chapel Hill. |

Facebook
X
LinkedIn
Forward
